Shelley Kuang
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.
Journal: JTO clinical and research reports
Published: August 15, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastases.
Journal: Therapeutic advances in medical oncology
Published: May 12, 2025
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center Experience.
Journal: Current oncology (Toronto, Ont.)
Published: June 04, 2024
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression.
Journal: Current oncology (Toronto, Ont.)
Published: June 05, 2023
Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: May 14, 2022
Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief Report.
Journal: JTO clinical and research reports
Published: December 08, 2021
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy.
Journal: JTO clinical and research reports
Published: July 27, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026